Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ

NCT00567164 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1887

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception
Ovulation Inhibition
Contraceptives, Oral

Interventions

DRUG: EE20/DRSP (BAY86-5300)
DRUG: EE20/DRSP (BAY86-5300)
DRUG: EE20/DRSP (YAZ, BAY86-5300)

Sponsor

Bayer